Resmonics Company

Resmonics develops digital biomarkers based on state-of-the-art mobile sensing technology to enable respiratory disease monitoring among patients with asthma or COPD (Chronic obstructive pulmonary disease).

Investors

Industry: PharmTech
Headquarters: Zurich
Visit Website
Register and Claim Ownership